BIOX ApS: Financial statements 2025
CVR: 40237216
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BIOX ApS (CVR 40237216) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 20,636 and a net result of DKK 15,931 compared with DKK -5,706 the year before. Equity in the 2025 report amounted to DKK 1,007,937. The solvency ratio was 91%.
- Gross Profit
- DKK 20,636
- Profit/Loss
- DKK 15,931
- Equity
- DKK 1,007,937
- Total Assets
- DKK 1,107,577
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 21 t. | 16 t. | 1 mio. | - |
| 2024 | - | -7 t. | -6 t. | 992 t. | - |
| 2023 | - | -26 t. | -21 t. | 998 t. | - |
| 2022 | - | 2 t. | -69 t. | 515 t. | 1 |
| 2021 | - | -71 t. | -70 t. | 584 t. | 1 |
How creditworthy is BIOX ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BIOX ApS has published its annual report for 2024. Gross profit came to DKK -7,091, and the net result was DKK -5,706.
About BIOX ApS
BIOX ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Morten Lindblad. The company's owners include LOVISION ApS, BiA ApS and Genesis Invest ApS. In 2025, the company reported a gross profit of DKK 20,636 and a net result of DKK 15,931 compared with DKK -5,706 the year before. Equity in the 2025 report amounted to DKK 1,007,937.